A survey of alternative transcripts of human tissue kallikrein genes

被引:70
作者
Kurlender, L
Borgono, C
Michael, IP
Obiezu, C
Elliott, MB
Yousef, GM
Diamandis, EP
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada
[3] Mem Univ Newfoundland, Discipline Lab Med, St John, NF A1B 3V6, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2005年 / 1755卷 / 01期
基金
加拿大自然科学与工程研究理事会;
关键词
kallikrein; alternative splicing; differential expression; serine protease; splice variant; cancer biomarker;
D O I
10.1016/j.bbcan.2005.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing is prevalent within the human tissue kallikrein gene locus. Aside from being the most important source of protein diversity in eukaryotes, this process plays a significant role in development, physiology and disease. A better understanding of alternative splicing could lead to the use of gene variants as drug targets, therapeutic agents or diagnostic markers. With the rapidly rising number of alternative kallikrein transcripts, classifying new transcripts and piecing together the significance of existing data are becoming increasingly challenging. In this review, we present a systematic analysis of all currently known kallikrein alternative transcripts. By defining a reference form for each of the 15 kallikrein genes (KLK1 to KLK15), we were able to classify alternative splicing patterns. We identified 82 different kallikrein gene transcript forms, including reference forms. Alternative splicing may lead to the synthesis of 56 different protein forms for KLK1-15. In the kallikrein locus, the majority of alternative splicing events occur within the protein-coding region, and to a lesser extent in the 5' untranslated regions (UTRs). The most common alternative splicing event is exon skipping (35%) and the least common events are cryptic exons (3%) and internal exon deletion (3%). Seventy-six percent of kallikrein splice variants that are predicted to encode truncated proteins are the result of frameshifts. Eighty-nine percent of putative proteins encoded by splice variants are predicted to be secreted. Although several reports describe the identification of kallikrein splice variants and their potential clinical utility, this is the first extensive review on this subject. Accumulating evidence suggests that alternative kallikrein forms could be involved in many pathologic conditions or could have practical applications as biomarkers. The organization and analysis of the kallikrein transcripts will facilitate future work in this area and may lead to novel clinical and diagnostic applications. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 93 条
[1]   CLONING AND EXPRESSION OF HUMAN SALIVARY-GLAND KALLIKREIN IN ESCHERICHIA-COLI [J].
ANGERMANN, A ;
BERGMANN, C ;
APPELHANS, H .
BIOCHEMICAL JOURNAL, 1989, 262 (03) :787-793
[2]   A novel protease homolog differentially expressed in breast and ovarian cancer [J].
Anisowicz, A ;
Sotiropoulou, G ;
Stenman, G ;
Mok, SC ;
Sager, R .
MOLECULAR MEDICINE, 1996, 2 (05) :624-636
[3]  
[Anonymous], GENES
[4]   HUMAN-KIDNEY KALLIKREIN - CDNA CLONING AND SEQUENCE-ANALYSIS [J].
BAKER, AR ;
SHINE, J .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1985, 4 (06) :445-450
[5]   THE POLY(A)-POLY(A)-BINDING PROTEIN COMPLEX IS A MAJOR DETERMINANT OF MESSENGER-RNA STABILITY INVITRO [J].
BERNSTEIN, P ;
PELTZ, SW ;
ROSS, J .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :659-670
[6]  
Borgoño CA, 2004, MOL CANCER RES, V2, P257
[7]   ALTERNATIVE SPLICING - A UBIQUITOUS MECHANISM FOR THE GENERATION OF MULTIPLE PROTEIN ISOFORMS FROM SINGLE GENES [J].
BREITBART, RE ;
ANDREADIS, A ;
NADALGINARD, B .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :467-495
[8]   EST comparison indicates 38% of human mRNAs contain possible alternative splice forms [J].
Brett, D ;
Hanke, J ;
Lehmann, G ;
Haase, S ;
Delbrück, S ;
Krueger, S ;
Reich, J ;
Bork, P .
FEBS LETTERS, 2000, 474 (01) :83-86
[9]   Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing [J].
Castle, J ;
Garrett-Engele, P ;
Armour, CD ;
Duenwald, SJ ;
Loerch, PM ;
Meyer, MR ;
Schadt, EE ;
Stoughton, R ;
Parrish, ML ;
Shoemaker, DD ;
Johnson, JM .
GENOME BIOLOGY, 2003, 4 (10)
[10]  
Chang A, 2001, ANTICANCER RES, V21, P3147